These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 25156113)
1. A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: worth the risk? Mangioni D; Muscatello A; Sabbatini F; Soria A; Rossi M; Bisi L; Squillace N; De Grandi C; Gori A; Bandera A Clin Infect Dis; 2014 Dec; 59(11):1655-6. PubMed ID: 25156113 [No Abstract] [Full Text] [Related]
2. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting. Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289 [TBL] [Abstract][Full Text] [Related]
3. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children]. Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718 [TBL] [Abstract][Full Text] [Related]
4. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma. Monteiro de Almeida S; Letendre S; Zimmerman J; Lazzaretto D; McCutchan A; Ellis R J Neuroimmunol; 2005 Dec; 169(1-2):144-52. PubMed ID: 16182380 [TBL] [Abstract][Full Text] [Related]
5. Rapid decay of HIV RNA in the cerebrospinal fluid during antiretroviral combination therapy. Stellbrink HJ; Eggers C; van Lunzen J; Albrecht H; Greten H AIDS; 1997 Nov; 11(13):1655-7. PubMed ID: 9365775 [No Abstract] [Full Text] [Related]
6. Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus. Bogoch II; Davis BT; Venna N J Infect; 2011 Sep; 63(3):236-9. PubMed ID: 21658774 [TBL] [Abstract][Full Text] [Related]
7. A case of multidrug resistance in the central nervous system. McCarty EJ; Quah SP; Dinsmore WW; Emerson CR Int J STD AIDS; 2010 Nov; 21(11):777-9. PubMed ID: 21187362 [TBL] [Abstract][Full Text] [Related]
8. A rare case of HIV CNS escape in a patient previously considered a viral controller. Magid-Bernstein J; Guo CY; Chow FC; Thakur KT Int J STD AIDS; 2020 Jun; 31(7):694-698. PubMed ID: 32538333 [TBL] [Abstract][Full Text] [Related]
9. Recurrent cerebrospinal fluid escape in an HIV-1-infected patient receiving antiretroviral therapy. Martins J; Santos E; Salgado P; Maia L; Dias D; Marta M; França M AIDS; 2016 Apr; 30(7):1143-4. PubMed ID: 27028145 [No Abstract] [Full Text] [Related]
10. History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change. Reekie J; Mocroft A; Ledergerber B; Beniowski M; Clotet B; van Lunzen J; Chiesi A; Pradier C; Machala L; Lundgren JD; HIV Med; 2010 Aug; 11(7):469-78. PubMed ID: 20201975 [TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammation. Probasco JC; Deeks SG; Lee E; Hoh R; Hunt PW; Liegler T; Price RW; Spudich SS AIDS; 2010 Apr; 24(7):1001-5. PubMed ID: 20299968 [TBL] [Abstract][Full Text] [Related]
12. [Cerebrospinal fluid viral load in HIV-1 positive hemophilic patients treated with HAART]. Corti ME; Villafañe MF; Baré P; Alves Rosa F; Cermelj M; Candela M; Pérez Bianco R; Tezanos Pinto M Medicina (B Aires); 2001; 61(6):821-4. PubMed ID: 11808421 [TBL] [Abstract][Full Text] [Related]
13. Ongoing HIV replication in cerebrospinal fluid under successful monotherapy. Bierhoff M; Boucher CA; Fibriani A; Ten Kate RW Antivir Ther; 2013; 18(4):641-3. PubMed ID: 23344463 [TBL] [Abstract][Full Text] [Related]
14. Association between atazanavir plasma levels and renal function in HIV-positive individuals on antiretroviral therapy with undetectable viral load. Luz AJ; Poeta J; Linden R; Antunes MV; Caminha LI; Callegari-Jacques SM; Sprinz E Int J Antimicrob Agents; 2013 May; 41(5):497-8. PubMed ID: 23453620 [No Abstract] [Full Text] [Related]
15. Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy. Ellis RJ; Childers ME; Zimmerman JD; Frost SD; Deutsch R; McCutchan JA; J Infect Dis; 2003 Jun; 187(11):1818-21. PubMed ID: 12751041 [TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen. Yilmaz A; Ståhle L; Hagberg L; Svennerholm B; Fuchs D; Gisslén M Scand J Infect Dis; 2004; 36(11-12):823-8. PubMed ID: 15764168 [TBL] [Abstract][Full Text] [Related]
17. Neurosymptomatic cerebrospinal fluid escape in HIV-2: a case report. Kulkarni V; Kulkarni R; Parchure R Int J STD AIDS; 2018 Jun; 29(7):726-728. PubMed ID: 29251118 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of dosage adjustments used to manage antiretroviral drug interactions. Park-Wyllie LY; Levine MA; Holbrook A; Thabane L; Antoniou T; Yoong D; Kam D; Bayoumi AM Clin Infect Dis; 2007 Oct; 45(7):933-6. PubMed ID: 17806064 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment. Mellgren A; Antinori A; Cinque P; Price RW; Eggers C; Hagberg L; Gisslén M Antivir Ther; 2005; 10(6):701-7. PubMed ID: 16218168 [TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations of discordance between cerebrospinal fluid and plasma HIV-1 loads. Jenny-Avital ER; Chuang C Clin Infect Dis; 2002 Dec; 35(12):1576-7. PubMed ID: 12471586 [No Abstract] [Full Text] [Related] [Next] [New Search]